What is the recommended dose of albendazole (anti-parasitic medication) for pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Albendazole Dosing in Pediatric Patients

For children over 24 months of age, the standard dose is 400 mg as a single dose for most common parasitic infections including hookworm, pinworm, and ascariasis. 1, 2, 3

Standard Dosing by Age Group

Children Over 24 Months

  • Single-dose therapy: 400 mg as a single dose for hookworm, ascariasis, enterobiasis (pinworm), and trichinellosis 1, 2, 3
  • Extended therapy: 400 mg daily for 3-21 days depending on the specific parasite 3
  • Albendazole should be taken with food to improve absorption 4

Children Under 24 Months (12-24 months)

  • Expert consultation is required before administering albendazole for asymptomatic eosinophilia in this age group due to limited safety and efficacy data 2, 3
  • For children 8-24 months with documented helminth infections, a dose of 200 mg as a single dose has been studied and shown to be effective and safe 5

Weight-Based Dosing for Specific Conditions

For neurocysticercosis and hydatid disease in children weighing less than 60 kg:

  • 15 mg/kg/day divided into two doses (maximum 800 mg total daily dose) 4
  • Duration: 8-30 days for neurocysticercosis; 28-day cycles for hydatid disease 4

Infection-Specific Dosing

Common Intestinal Helminths

  • Hookworm: 400 mg single dose 1
  • Pinworm (Enterobius): 400 mg single dose 1
  • Ascariasis (roundworm): 400 mg single dose 1

Complex Parasitic Infections

  • Trichinellosis (mild): 400 mg once daily for 3 days 1
  • Visceral larva migrans (Toxocara): 400 mg twice daily for 5 days 3
  • Ocular toxocariasis: 400 mg twice daily for 3-14 days depending on severity 3
  • Capillariasis: 400 mg twice daily for 21 days with monitoring 3
  • Giardiasis: 400 mg once daily for 5 days (95% cure rate) 6

Immunocompromised Patients

  • Microsporidiosis: 7.5 mg/kg twice daily until immune reconstitution 2, 7

Administration Guidelines

  • Tablets may be crushed or chewed and swallowed with water 4
  • Always administer with food to enhance absorption 4
  • Fatty meals further improve absorption for extended treatment courses 7

Monitoring Requirements

For treatment courses longer than 14 days, the following monitoring is essential:

  • Liver enzymes (transaminases) at baseline and every 2 weeks 7, 3, 4
  • Complete blood counts at baseline and every 2 weeks to monitor for leukopenia 7, 4
  • Liver function tests specifically for capillariasis treatment 3

Retreatment Considerations

  • Repeat dosing after 2-8 weeks may be necessary for certain helminth infections to treat residual worms that have matured into adults 2, 3
  • For Loeffler syndrome without identified organism, retreatment 1 month after resolution of pulmonary symptoms is recommended 3

Special Clinical Situations

Neurocysticercosis

  • Concomitant corticosteroids (oral or intravenous) should be administered to prevent cerebral hypertensive episodes during the first week of treatment 4
  • Anticonvulsant therapy should be provided as required 4

Pregnancy Testing

  • Obtain pregnancy test in females of reproductive potential prior to initiating therapy 4

Common Pitfalls to Avoid

  • Do not underdose based on age alone - children over 24 months require the full 400 mg dose, not weight-based reductions for common infections 1, 2
  • Do not skip monitoring for extended courses - hepatotoxicity and bone marrow suppression can occur 7, 4
  • Do not administer without food - bioavailability is significantly reduced on an empty stomach 4
  • Do not assume single-dose efficacy for all parasites - some infections require multi-day regimens 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Albendazole Treatment Guidelines for Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Dosing of Albendazole in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Albendazole as a treatment for infections with Giardia duodenalis in children in Bangladesh.

Transactions of the Royal Society of Tropical Medicine and Hygiene, 1993

Guideline

Albendazole Treatment Guidelines for Parasitic Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.